LifeStance Health Group, Inc.
HealthcareNASDAQ:LFST · NASDAQ Global Select
-$0.11 today
Vol 2.68M · Avg 3.84M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
0.6%
avg -8.2%
ROIC
0.9%
avg -4.0%
ROA
0.4%
avg -5.3%
Analysis
ROIC is currently the strongest return metric at 0.9% versus its period average of -4.0%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Ryan Bruce McGroarty | Chief Financial Officer & Treasurer | $1.52M | — | 53 | $1.09M | 0.28% |
David Patrick Bourdon | Chief Executive Officer & Director | $1.39M | — | 57 | $1.48M | 0.38% |
Kenneth Alan Burdick | Executive Chairman | $650,154.00 | — | 67 | $2.98M | 0.77% |
Vukasin Paunovich | Chief Technology Officer | $644,201.00 | — | 54 | $327,837.00 | 0.08% |
Ryan Pardo | Chief Legal Officer & Secretary | $558,251.00 | — | 49 | $1.09M | 0.28% |
Ann Varanakis | Chief People Officer | $558,251.00 | — | 48 | $387,272.00 | 0.10% |
Lisa Keise Miller | Chief Operating Officer & Principal Operating Officer | — | — | 52 | $342,647.00 | 0.09% |
Monica Prokocki | Vice President of Investor Relations | — | — | — | — | — |
Toi Valentine | Senior Vice President & Chief Strategy Officer | — | — | — | — | — |
Brooke Matthews | Director of Public Relations | — | — | — | — | — |
Stephanie C. Eken | Chief Medical Officer | — | — | 50 | $115,107.00 | 0.03% |
Dan Ferris | Chief Growth Officer | — | — | — | — | — |
Richard Hall | Chief Shared Services Officer | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
5
$498,293.90
Sells
31
$562.89M
Net Sentiment
$562.40M
Net selling
Most Active
Bessler Robert
20 transactions
1–10 of 36
Analysis
Insiders reported 5 buys worth $498,293.90 and 31 sells worth $562.89M over the last 12 months. That adds up to net selling of $562.40M. Bessler Robert was the most active insider with 20 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A4 analysts |
| Revenue | N/A | N/A | +40.9% | +15.5% (5yr)6 analysts |
| Net Income | N/A | N/A | N/A | N/A6 analysts |
| EBIT | N/A | N/A | N/A | N/A6 analysts |
Analysis
Recent growth has been strongest in Revenue at +40.9% over three years. Forward estimates point to Revenue at +15.5% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Brookdale Senior Living Inc.
NYSE:BKD
$3.21B
National HealthCare Corporation
AMEX:NHC
$3.09B
Clover Health Investments, Corp.
NASDAQ:CLOV
$2.45B
Acadia Healthcare Company, Inc.
NASDAQ:ACHC
$2.26B
Select Medical Holdings Corporation
NYSE:SEM
$2.07B
Pediatrix Medical Group, Inc.
NYSE:MD
$2.00B
Astrana Health, Inc.
NASDAQ:ASTH
$1.91B
Addus HomeCare Corporation
NASDAQ:ADUS
$1.74B
Aveanna Healthcare Holdings Inc.
NASDAQ:AVAH
$1.54B
Ardent Health Partners, LLC
NYSE:ARDT
$1.34B
Who manages LFST?
LifeStance Health Group, Inc. (LFST) lists 13 active executives. The top listed executive is Vukasin Paunovich, Chief Technology Officer.
Are LFST insiders buying or selling?
Recent insider activity shows net selling of $752.43M.
Explore More
Continue the stock analysis
Jump to another research area for this company.